Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.60
+1.75 (25.55%)
Mar 9, 2026, 2:07 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $223.63 million as of March 9, 2026. Its market cap has decreased by -55.67% in one year.
Market Cap
223.63M
Enterprise Value
108.83M
1-Year Change
-55.67%
Ranking
Category
Stock Price
$8.60
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $223.63M, an increase of 34.66%. That is a compound annual growth rate of 13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 178.12M | -4.99% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 232.33M |
| Eledon Pharmaceuticals | 231.71M |
| Protalix BioTherapeutics | 227.59M |
| Voyager Therapeutics | 227.40M |
| Achieve Life Sciences | 226.78M |
| Sol-Gel Technologies | 223.50M |
| Keros Therapeutics | 220.44M |
| MediWound | 217.86M |